ArticleReaction kinetics, mechanisms and catalysis2026
Octahedral [(8-quinolinyl/phenanthridinyl)amine)Ga(III)] complexes, reactivity, affinity for biomolecules, anti-cancer and computational evaluations.
Article in Reaction kinetics, mechanisms and catalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Octahedral iodo gallium(III) complexes, GaL1-L3(SN)I, incorporating bis-(azaaryl)amine ligands (L1-L3) with varying conformational flexibility, were synthesized and characterized by spectroscopic and elemental analyses to evaluate ligand effects on reactivity and affinity for biological targets. Iodide substitution by biologically relevant nucleophiles (guanine and thiourea), monitored spectrophotometrically, revealed ligand-dependent rates, with the fastest substitution observed for the dicationic GaL1(SN)I bearing the most compact and flexible ligand (L1), compared to the more rigid monocationic L2 and L3 analogues. UV-Visible studies of interactions with bovine serum albumin and calf thymus DNA indicated moderate to strong binding ( Supplementary Information: The online version contains supplementary material available at 10.1007/s11144-026-03129-6.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.